| Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (NCT00898287) | Piramal Enterprises Limited | 2009-05-01 |
| Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device (NCT00889668) | Integrity Applications Ltd. | 2009-05-01 |
| Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers (NCT00908362) | University of Rostock | 2009-05-01 |
| Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation (NCT00768729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Phase I Combination Ixabepilone + Cisplatin (NCT00832117) | R-Pharm | 2009-05-01 |
| Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria (NCT01060891) | Poitiers University Hospital | 2009-05-01 |
| An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence (NCT01062451) | Baylor College of Medicine | 2009-05-01 |
| Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malaria (NCT00870987) | U.S. Army Medical Research and Development Command | 2009-05-01 |
| A Study of Oraxol® in Gastric Cancer Patients (NCT01491217) | Hanmi Pharmaceutical Company Limited | 2009-05-01 |
| Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety (NCT01187784) | Alliant International University | 2009-05-01 |
| Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS) (NCT00907153) | Milton S. Hershey Medical Center | 2009-05-01 |
| Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers (NCT02195804) | Boehringer Ingelheim | 2009-05-01 |
| Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy Volunteers (NCT00908726) | Asan Medical Center | 2009-05-01 |
| Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus (NCT00880789) | Baylor College of Medicine | 2009-05-01 |
| Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) (NCT00987831) | Oklahoma Medical Research Foundation | 2009-05-01 |
| Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure (NCT00912184) | Austin Health | 2009-05-01 |
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients (NCT00907166) | Cornerstone Pharmaceuticals | 2009-05-01 |
| A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel (NCT00868361) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-05-01 |
| A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) (NCT00902161) | Merck Sharp & Dohme LLC | 2009-05-01 |
| Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions (NCT00878514) | Orion Corporation, Orion Pharma | 2009-05-01 |
| Single-dose Escalation Trial of M2ES in Healthy Volunteer (NCT01223924) | Protgen Ltd | 2009-05-01 |
| Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT00905398) | Rony Schaffel | 2009-05-01 |
| Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease (NCT00847210) | Takeda | 2009-05-01 |
| Effects of Breezy Candy on Halitosis (NCT00875927) | Breezy Industries Ltd. | 2009-05-01 |
| Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT01017133) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |
| Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions (NCT01326195) | Rhode Island Hospital | 2009-05-01 |
| Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer (NCT00892567) | Craig L Slingluff, Jr | 2009-05-01 |
| Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma (NCT00964080) | Mebiopharm Co., Ltd | 2009-05-01 |
| Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases (NCT00807170) | Sanofi | 2009-05-01 |
| Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients (NCT00997022) | Columbia University | 2009-05-01 |
| Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML (NCT00895934) | National Cancer Institute (NCI) | 2009-05-01 |
| A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab (NCT00875979) | Hoffmann-La Roche | 2009-05-01 |
| Intermittent Theta Burst Stimulation After Acute Stroke (NCT01323881) | Taipei Veterans General Hospital, Taiwan | 2009-05-01 |
| Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease (NCT00911495) | GlycoMimetics Incorporated | 2009-05-01 |
| Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy (NCT00863850) | Cephalon | 2009-05-01 |
| Launch II: A Pilot Randomized Control Trial of a Clinic and Clinic Plus Home Intervention for Preschool Obesity (NCT01419951) | Children's Hospital Medical Center, Cincinnati | 2009-05-01 |
| A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects (NCT00914511) | VIVUS LLC | 2009-05-01 |
| Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity (NCT00897676) | Diva De Leon | 2009-05-01 |
| Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults (NCT00895544) | Alachua Government Services, Inc. | 2009-05-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043 (NCT00918515) | AstraZeneca | 2009-05-01 |
| CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction (NCT00893360) | Cedars-Sinai Medical Center | 2009-05-01 |
| Vorinostat Plus Radiation Therapy in Pancreatic Cancer (NCT00831493) | M.D. Anderson Cancer Center | 2009-05-01 |
| Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes (NCT00896077) | DiaKine Therapeutics, Inc. | 2009-05-01 |
| Amicar Pharmacokinetics of Children Having Craniofacial Surgery (NCT00912119) | Paul Stricker | 2009-05-01 |
| AZD9056 Relative Bioavailability Study (NCT00908934) | AstraZeneca | 2009-05-01 |
| Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder (NCT01871974) | Astellas Pharma Inc | 2009-05-01 |
| Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients (NCT00888628) | Massachusetts General Hospital | 2009-05-01 |
| Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa (NCT01068561) | University of Sao Paulo | 2009-05-01 |
| A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women (NCT00902356) | Amgen | 2009-05-01 |
| A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD) (NCT00890292) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-05-01 |
| A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors (NCT00879905) | Novartis Pharmaceuticals | 2009-05-01 |
| Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites (NCT01515891) | Bial - Portela C S.A. | 2009-05-01 |
| Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke (NCT00870844) | H. Lundbeck A/S | 2009-05-01 |
| A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects (NCT00902187) | Pfizer | 2009-05-01 |
| Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy (NCT00886795) | Johns Hopkins University | 2009-05-01 |
| Study Evaluating BLI-489 and Piperacillin in Healthy Subjects (NCT00894439) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-05-01 |
| Study of the Effect of Food on the Pharmacokinetics of Mirabegron (NCT00939757) | Astellas Pharma Inc | 2009-05-01 |
| Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E (NCT00907400) | AstraZeneca | 2009-05-01 |
| Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis (NCT01220492) | Beijing 302 Hospital | 2009-05-01 |
| 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients (NCT00905632) | Boehringer Ingelheim | 2009-05-01 |
| A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g) (NCT00851136) | Genentech, Inc. | 2009-05-01 |
| Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma (NCT00730652) | Bristol-Myers Squibb | 2009-05-01 |
| Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients (NCT00767546) | Rabin Medical Center | 2009-05-01 |
| A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers. (NCT00862667) | Pfizer | 2009-05-01 |
| Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents (NCT00907062) | University of Toronto | 2009-05-01 |
| Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir (NCT00909311) | Abbott | 2009-05-01 |
| Erlotinib and Temsirolimus for Solid Tumors (NCT00770263) | Washington University School of Medicine | 2009-05-01 |
| Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer (NCT00901732) | Jazz Pharmaceuticals | 2009-05-01 |
| The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects (NCT00911235) | Pfizer | 2009-05-01 |
| Occlusal Adjustment as Treatment for Chronic Orofacial Pain (NCT00899717) | University of Santiago de Compostela | 2009-05-01 |
| Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) (NCT00816465) | Hadassah Medical Organization | 2009-05-01 |
| Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer (NCT00900614) | Aprea Therapeutics | 2009-05-01 |
| A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants (NCT01986491) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-05-01 |
| Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease (NCT00901498) | Bristol-Myers Squibb | 2009-05-01 |
| Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS) (NCT00890565) | Kyowa Kirin Co., Ltd. | 2009-05-01 |
| Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer (NCT00909558) | Envita Medical Center, Inc. | 2009-05-01 |
| XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib (NCT00920868) | Herbert Hurwitz, MD | 2009-05-01 |
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY (NCT00809276) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-05-01 |
| Vitamin D Supplementation in Crohn's Patients (NCT00742781) | Penn State University | 2009-05-01 |
| Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease (NCT02055261) | Pitié-Salpêtrière Hospital | 2009-05-01 |
| Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors (NCT01386866) | Amgen | 2009-05-01 |
| Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy (NCT00889954) | Baylor College of Medicine | 2009-05-01 |
| A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects (NCT01812538) | Hospira, now a wholly owned subsidiary of Pfizer | 2009-05-01 |
| Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis (NCT00872729) | Amgen | 2009-05-01 |
| Staccato Loxapine Pulmonary Safety in Patients With Asthma (NCT00890175) | Alexza Pharmaceuticals, Inc. | 2009-05-01 |
| Feasibility Study of the Solo™ Insulin Pump (NCT01055951) | Medingo Ltd | 2009-05-01 |
| Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects (NCT00918164) | Pfizer | 2009-05-01 |
| Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer (NCT00903214) | Barbara Ann Karmanos Cancer Institute | 2009-05-01 |
| A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers (NCT00924768) | University of North Carolina, Chapel Hill | 2009-05-01 |
| Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers (NCT02172196) | Boehringer Ingelheim | 2009-05-01 |
| Effects of GSK598809 on Brain Activation in Abstinent Alcoholics (NCT00908206) | GlaxoSmithKline | 2009-05-01 |
| PRO#0118: Decitabine Plus Mini Flu-Bu (NCT01455506) | Hackensack Meridian Health | 2009-05-01 |
| Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects (NCT00893971) | Pearl Therapeutics, Inc. | 2009-05-01 |
| RNActive®-Derived Therapeutic Vaccine (NCT00906243) | University of Florida | 2009-05-01 |
| Prevention of Post Sexual Assault Stress (NCT01430624) | Medical University of South Carolina | 2009-05-01 |
| Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder (NCT00892021) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-05-01 |
| NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia (NCT00910741) | NanoCarrier Co., Ltd. | 2009-05-01 |
| Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer (NCT01086332) | University of Iowa | 2009-05-01 |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma (NCT01449942) | Xiangya Hospital of Central South University | 2009-05-01 |
| An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects (NCT00879983) | Pfizer | 2009-05-01 |